Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L1VP
|
|||
| Former ID |
DIB015462
|
|||
| Drug Name |
NX-CP105
|
|||
| Synonyms |
Stem cell therapy (myocardial infarction), Neuronyx; HAMB-SC (ischemic diseases), Neuronyx; Human adult bone marrow-derived somatic cells (ischemic diseases), Neuronyx
Click to Show/Hide
|
|||
| Indication | Cerebrovascular ischaemia [ICD-11: 8B1Z; ICD-10: I67.8; ICD-9: 434.91] | Phase 1 | [1] | |
| Company |
Garnet BioTherapeutics Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00361855) Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.